Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Methotrexate Patterns of Use, Clearance, Toxicities, Supportive Care and Outcomes

NCT05899751 is registered in ClinicalTrials.gov with Protherics Medicines Development Limited as lead sponsor.

NCT NCT05899751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05899751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Methotrexate Patterns of Use, Clearance, Toxicities, Supportive Care and Outcomes
Lead sponsor
Protherics Medicines Development Limited
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
December 31, 2024
Enrollment
1,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, drug toxicity